Genetics

Photo

News • GATA2 deficiency

New gene-editing technology could help treat rare diseases

Researchers have successfully corrected part of a genetic defect in stem cells taken from a patient with GATA2 deficiency. This could have significant implications for patients with genetic disorders.

Photo

News • Oncology

DNA in blood signals cancer risk years ahead

DNA methylation patterns in blood could identify people at high risk of prostate or breast cancer up to eight years before diagnosis, Oxford Population Health researchers report.

Photo

News • New approach to limit infections

Cystic fibrosis: restoring the respiratory protective barrier

To fight cystic fibrosis at the source, scientists have both identified a key infection mechanism and a way to correct the defect. Their insights could help limit serious complications in CF patients.

Photo

News • Research explores key role of chromatin

Kabuki syndrome: new insights offer hope for therapies

New research has identified a previously unknown mechanism of Kabuki syndrome, a rare genetic disorder. The discovery could open new therapeutic perspectives.

Photo

News • Fluorescence lifetime imaging microscopy

New technique could aid targeted lung cancer treatment

Detecting genetic mutations associated with lung cancer via laboratory tests can be expensive and time-consuming, and use up valuable tissue from small biopsy samples. A new approach aims to fix this.

Photo

News • CRISPR-Cas9-based approach

New laboratory tool to find better treatments for resistant melanomas

Researchers have developed a new lab model to study BAP1-deficient melanomas, a rare type of melanoma that evade the immune system once they metastasize and are resistant to current immunotherapies.

Photo

Article • Personalised medicine

Gene-editing technologies: from lab to patient

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of genetic diseases. At the 2025 World Medical Innovation Forum in Boston, leading experts explored the possibilities and challenges of these rapidly advancing tools. The case of Baby KJ Muldoon – an infant treated with a personalised CRISPR therapy developed in just seven…

397 show more articles
Subscribe to Newsletter